Publications:  Mr Daniel Vulkan

Ghimire B, Maroni R, Vulkan D, Shah Z, Gaynor E, Timoney M, Jones L, Arvanitis R et al.(2020). Erratum to “Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme” (Lung Cancer (2019) 134 (66–71), (S0169500219304702), (10.1016/j.lungcan.2019.05.026)). Lung Cancer vol. 139,

Ghimire B, Maroni R, Vulkan D, Shah Z, Gaynor E, Timoney M, Jones L, Arvanitis R et al.(2019). Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme. Lung Cancer vol. 134, 66-71.

Aarts AMWM, Duffy SW, Geurts SME, Vulkan DP, Houssami N, Zappa M, Nagtegaal ID, Verbeek ALM et al.(2019). Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. Breast vol. 45, 70-74.

von Wagner C, Hirst Y, Tookey S, Kerrison RS, Marshall S, Prentice A, Vulkan D, Macleod U et al.(2018). Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population. BMJ Open vol. 8, (5) e022263-e022263.

Burnside ES, Vulkan D, Blanks RG, Duffy SW(2018). Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study. Radiology vol. 288, (1) 47-54.

Aarts AMWM, Duffy SW, Geurts SME, Vulkan DP, Otten JDM, Hsu CY, Chen THH, Verbeek ALM et al.(2018). Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands). Journal of Medical Screening

Benton SC, Butler P, Allen K, Chesters M, Rickard S, Stanley S, Roope R, Vulkan D et al.(2017). GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. Br J Cancer vol. 116, (12) 1551-1557.